The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
Aging2022Vol. 14(22), pp. 8927–8943
Citations Over TimeTop 18% of 2022 papers
Takehiko Yamanashi, Zoe-Ella EM Anderson, Manisha Modukuri, Gloria Chang, Tammy Tran, Pedro S. Marra, Nadia E. Wahba, Kaitlyn J. Crutchley, Eleanor J. Sullivan, Sydney S. Jellison, Katie R. Comp, Cade C. Akers, Alissa A. Meyer, Sangil Lee, Masaaki Iwata, Hyunkeun R. Cho, Eri Shinozaki, Gen Shinozaki
Abstract
Metformin use may lower the risk of delirium and mortality in DM patients.
Related Papers
- → Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences(2018)251 cited
- A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity(2007)
- → Metformin for Prevention of Type 2 Diabetes(2004)11 cited
- Advances in the study on metformin beyond its hypoglycemic effect(2013)
- 당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과(2012)